📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Therapeutic targeting of preleukemia cells in a mouse model of NPM1 mutant acute myeloid leukemia. (2020)

First Author: Uckelmann HJ

Attributed to: Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’ funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1126/science.aax5863

PubMed Identifier: 32001657

Publication URI: http://europepmc.org/abstract/MED/32001657

Type: Journal Article/Review

Volume: 367

Parent Publication: Science (New York, N.Y.)

Issue: 6477

ISSN: 0036-8075